Evidence map›Paper›PMID 30112577›Full record

ArticlePsychopharmacology2019

Prazosin during fear conditioning facilitates subsequent extinction in male C57Bl/6N mice.

Elizabeth K Lucas, Wan-Chen Wu, Ciorana Roman-Ortiz, Roger L Clem

Abstract read
In one paragraph

Article in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Neurochemical Effects of Prazosin Treatment on Fear Circuitry in a Rat Traumatic Stress Model.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2020
    Article
  9. αFrontiers in pharmacology · 2020
    Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elizabeth K LucasFishberg Department of Neuroscience and the Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, Box 1065, New York, NY, 10029, USA.
Wan-Chen WuFishberg Department of Neuroscience and the Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, Box 1065, New York, NY, 10029, USA.
Ciorana Roman-OrtizFishberg Department of Neuroscience and the Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, Box 1065, New York, NY, 10029, USA.
Roger L ClemFishberg Department of Neuroscience and the Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, Box 1065, New York, NY, 10029, USA. roger.clem@mssm.edu.ORCID http://orcid.org/0000-0002-8965-9455
Allen Institute for Brain Science · US

Funding

Noradrenergic circuit mechanisms of persistent fearR01MH105414 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CLEM, ROGER L · 2015 to 2019
$2.3M
Prefrontal circuit mechanisms of threat conditioningR01MH116445 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CLEM, ROGER L · 2018 to 2022
$2.1M
Cellular substrates of early life traumaR21MH114170 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CLEM, ROGER L · 2018 to 2019
$466k
National Institute of Mental Health MH105414NIMH NIH HHS R01 MH105414NIMH NIH HHS R01 MH116445NIMH NIH HHS R21 MH114170
6 · The paper itself

Abstract

rationaleRecovery from a traumatic experience requires extinction of cue-based fear responses, a process that is impaired in post-traumatic stress disorder. While studies suggest a link between fear behavioral flexibility and noradrenaline signaling, the role of specific receptors and brain regions in these effects is unclear.

objectivesHere, we examine the role of prazosin, an α1-adrenergic receptor (α1-AR) antagonist, in auditory fear conditioning and extinction.

methodsC57Bl/6N mice were subjected to auditory fear conditioning and extinction in combination with systemic (0.1-2 mg/kg) or local microinjections (3 or 6 mM) of the α1-AR antagonist prazosin into the prelimbic division of medial prefrontal cortex or basolateral amygdala. Conditioned fear and anxiety-like behaviors were compared with vehicle-injected control animals.

resultsMice that received systemic prazosin prior to fear conditioning exhibited similar initial levels of cue-elicited freezing compared to vehicle controls on the following day. However, at all doses tested, fear that was acquired during prazosin treatment was more readily extinguished, whereas anxiety-like behavior on the day of extinction was unaffected. A similar pattern of results was observed when prazosin was microinjected into the basolateral amygdala but not the prelimbic cortex. In contrast to pre-conditioning injections, prazosin administration prior to extinction had no effect on freezing.

conclusionsOur results indicate that α1-AR activity during aversive conditioning is dispensable for memory acquisition but renders conditioned fear more impervious to extinction. This suggests that behavioral flexibility is constrained by noradrenaline at the time of initial learning via activation of a specific AR isoform.

Indexed as

Adrenergic alpha-1 Receptor AntagonistsAnimalsAnxietyBasolateral Nuclear ComplexConditioning, PsychologicalExtinction, PsychologicalFearMaleMemoryMiceMice, Inbred C57BLPrazosinPrefrontal CortexAdrenergic alpha-1 Receptor AntagonistsPrazosinADRA1AExposure therapyTerazosin

Identifiers

PMID30112577
PMCPMC6374171
OpenAlexW2887123013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.